D. E. Shaw & Co., Inc. Clear Point Neuro, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $125 Billion
- Q2 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 289,823 shares of CLPT stock, worth $3.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
289,823
Previous 265,682
9.09%
Holding current value
$3.05 Million
Previous $3.16 Million
9.56%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CLPT
# of Institutions
102Shares Held
7.91MCall Options Held
116KPut Options Held
46.8K-
Vanguard Group Inc Valley Forge, PA1.48MShares$15.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA625KShares$6.59 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$3.86 Million0.0% of portfolio
-
State Street Corp Boston, MA333KShares$3.51 Million0.0% of portfolio
-
Morgan Stanley New York, NY332KShares$3.5 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $258M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...